Severe sepsis, defined as sepsis associated with acute organ dysfunction, r
esults from a generalized inflammatory and procoagulant host response to in
fection. Coagulopathy in severe sepsis is commonly associated with multiple
organ dysfunction, and often results in death. The molecule that is centra
l to these effects is thrombin, although it may also have anticoagulant and
antithrombotic effects through the activation of Protein C and induction o
f prostacyclin. In recent years, it has been recognized that chemicals prod
uced by endothelial cells play a key role in the pathogenesis of sepsis. Th
rombomodulin on endothelial cells coverts Protein C to Activated Protein C,
which has important antithrombotic, profibrinolytic and anti-inflammatory
properties. A number of studies have shown that Protein C levels are reduce
d in patients with severe infection, or even in inflammatory states without
infection. Because coagulopathy is associated with high mortality rates, a
nd animal studies have indicated that therapeutic intervention may result i
n improved outcomes, it was rational to initiate clinical studies.